Garivulimab
Garivulimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Garivulimab is under investigation in clinical trial NCT03379259 (Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors).
| Trade Name | Garivulimab |
| Generic | Garivulimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Garivulimab
